The shift toward dual-targeting bispecifics and the imminent arrival of highly efficacious triple combinations could shift the follicular lymphoma treatment space.
Guidelines | NCCN Guideline Update for Follicular Lymphoma: Translating NCCN Updates Into Follicular Lymphoma Practice
NCCN Guideline Update for Follicular Lymphoma: Translating NCCN Updates Into Follicular Lymphoma Practice
Videos
Optimally positioning CD19-directed therapies in the follicular lymphoma treatment sequence requires consideration of both efficacy and the risk of sacrificing future options.
Advertisement
Advertisement
Trending on AJMC
1
Top 5 Most-Read Multiple Sclerosis Articles of 2025
2
2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA
3
Top 5 Trending FDA Approvals of 2025
4
ICYMI: Highlights From Patient-Centered Oncology Care®
5
